1. Home
  2. YEXT vs DYN Comparison

YEXT vs DYN Comparison

Compare YEXT & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YEXT
  • DYN
  • Stock Information
  • Founded
  • YEXT 2006
  • DYN 1984
  • Country
  • YEXT United States
  • DYN United States
  • Employees
  • YEXT N/A
  • DYN N/A
  • Industry
  • YEXT EDP Services
  • DYN Medicinal Chemicals and Botanical Products
  • Sector
  • YEXT Technology
  • DYN Health Care
  • Exchange
  • YEXT Nasdaq
  • DYN Nasdaq
  • Market Cap
  • YEXT 747.5M
  • DYN 848.8M
  • IPO Year
  • YEXT 2017
  • DYN 2020
  • Fundamental
  • Price
  • YEXT $6.15
  • DYN $10.78
  • Analyst Decision
  • YEXT Strong Buy
  • DYN Strong Buy
  • Analyst Count
  • YEXT 3
  • DYN 12
  • Target Price
  • YEXT $9.00
  • DYN $47.73
  • AVG Volume (30 Days)
  • YEXT 817.5K
  • DYN 2.8M
  • Earning Date
  • YEXT 06-09-2025
  • DYN 05-05-2025
  • Dividend Yield
  • YEXT N/A
  • DYN N/A
  • EPS Growth
  • YEXT N/A
  • DYN N/A
  • EPS
  • YEXT N/A
  • DYN N/A
  • Revenue
  • YEXT $420,957,000.00
  • DYN N/A
  • Revenue This Year
  • YEXT $8.13
  • DYN N/A
  • Revenue Next Year
  • YEXT $5.85
  • DYN N/A
  • P/E Ratio
  • YEXT N/A
  • DYN N/A
  • Revenue Growth
  • YEXT 4.11
  • DYN N/A
  • 52 Week Low
  • YEXT $4.29
  • DYN $6.36
  • 52 Week High
  • YEXT $8.75
  • DYN $47.45
  • Technical
  • Relative Strength Index (RSI)
  • YEXT 51.04
  • DYN 57.30
  • Support Level
  • YEXT $5.87
  • DYN $7.38
  • Resistance Level
  • YEXT $6.26
  • DYN $8.01
  • Average True Range (ATR)
  • YEXT 0.28
  • DYN 0.91
  • MACD
  • YEXT 0.03
  • DYN 0.44
  • Stochastic Oscillator
  • YEXT 82.47
  • DYN 92.47

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: